AVE 0.00% 0.3¢ avecho biotechnology limited

Ann: Terumo Shifts Focus From Oxymorphone Patch to Injectables, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    Yep it's a huge blow. Is that the end of patch development? Been rejected multiple times now. Now they're back to 3 day and looking for a new partner. Animal doesn't work, patches don't work, can they find anything of commercial significance that will work? I am not convinced on injectables. Sorry moosey for the negative post.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.